About Entheon Biomedical
Entheon Biomedical is a company based in Vancouver (Canada) founded in 2006 was acquired by MPV Exploration in July 2020.. Entheon Biomedical has raised $77.28 thousand across 3 funding rounds from investors including MPV Exploration. Entheon Biomedical has completed 1 acquisition, including Lobo Gene. Entheon Biomedical operates in a competitive market with competitors including Clairvoyant Therapeutics, Nirvana Life Science and Alvarius, among others.
- Headquarter Vancouver, Canada
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Entheon Biomedical Corp.
-
Annual Revenue
$0 (USD)-100as on Nov 30, 2024
-
Net Profit
$-220.96 K (USD)-5.97as on Nov 30, 2024
-
EBITDA
$-231.21 K (USD)-6.35as on Nov 30, 2024
-
Total Equity Funding
$77.28 K (USD)
in 3 rounds
-
Latest Funding Round
$346.02 K (USD), Post-IPO
Jan 03, 2025
- Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
MPV Exploration
(Jul 02, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Entheon Biomedical
Entheon Biomedical is a publicly listed company on the CSE with ticker symbol ENBI in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Entheon Biomedical
Entheon Biomedical has successfully raised a total of $77.28K across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $346.02 thousand completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $346,021
-
First Round
First Round
(15 Jun 2020)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2025 | Amount | Post-IPO - Entheon Biomedical | Valuation |
investors |
|
| Apr, 2024 | Amount | Post-IPO - Entheon Biomedical | Valuation |
investors |
|
| Jun, 2020 | Amount | Seed - Entheon Biomedical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Entheon Biomedical
Entheon Biomedical has secured backing from 1 investor. Prominent investors backing the company include MPV Exploration. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Mineral exploration is focused on base metals projects.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Entheon Biomedical
Entheon Biomedical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Lobo Gene. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
DNA testing for personalized cannabis responses is provided.
|
2018 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Entheon Biomedical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Entheon Biomedical Comparisons
Competitors of Entheon Biomedical
Entheon Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Clairvoyant Therapeutics, Nirvana Life Science and Alvarius, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Psychedelic therapy drugs for addiction treatment are manufactured.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of opioid addiction
|
|
| domain | founded_year | HQ Location |
Develops bio-pharmaceutical treatments for addiction via psychedelics and therapy.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Entheon Biomedical
Frequently Asked Questions about Entheon Biomedical
When was Entheon Biomedical founded?
Entheon Biomedical was founded in 2006 and raised its 1st funding round 14 years after it was founded.
Where is Entheon Biomedical located?
Entheon Biomedical is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Is Entheon Biomedical a funded company?
Entheon Biomedical is a funded company, having raised a total of $77.28K across 3 funding rounds to date. The company's 1st funding round was a Seed of $77.28K, raised on Jun 15, 2020.
What does Entheon Biomedical do?
Entheon Biomedical was founded in 2006 and is based in Vancouver, Canada. Psychedelic medicines targeting addiction and substance abuse disorders are developed within the biotechnology sector. Serotonin receptor modulating molecules have been created, alongside patented formulations based on psilocybin and DMT. These efforts focus on therapeutic applications for treating various addiction-related conditions through innovative molecular approaches.
Who are the top competitors of Entheon Biomedical?
Entheon Biomedical's top competitors include Clairvoyant Therapeutics, Nirvana Life Science and Alvarius.
Is Entheon Biomedical publicly traded?
Yes, Entheon Biomedical is publicly traded on CSE under the ticker symbol ENBI.
How many acquisitions has Entheon Biomedical made?
Entheon Biomedical has made 1 acquisition, including Lobo Gene.
Who are Entheon Biomedical's investors?
Entheon Biomedical has 1 investor. Key investors include MPV Exploration.
What is Entheon Biomedical's ticker symbol?
The ticker symbol of Entheon Biomedical is ENBI on CSE.